 |
Tessera Therapeutics
Last updated: September 29, 2025
Founders: Geoffrey von Maltzahn, Jacob Rubens
USA | Funding: $581.8M (+)
Website: https://www.tesseratherapeutics.com/
Tessera Therapeutics is pioneering Gene Writing - a new genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source.
Website: https://www.tesseratherapeutics.com/
Tessera Therapeutics is pioneering Gene Writing - a new genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source.
